Results 101 to 110 of about 4,563 (204)

Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands

open access: yes, 2018
Lysophosphatidylinositols (LPIs) are membrane constituents that alter the properties of said membranes. However, recent data showing that the once orphan receptor, GPR55, can act as a receptor for LPIs has sparked a renewed interest in LPIs as bioactive ...
Al Houayek, Mireille   +5 more
core   +1 more source

New blood brothers: the GPR55 and CB2 partnership [PDF]

open access: yesCell Research, 2011
Endocannabinoids are increasingly being recognized as key lipid-derived regulators of immune function 1. Although the peripheral cannabinoid type 2 receptor (CB2) is thought to orchestrate many of these actions, additional non-CB1/CB2-mediated effects of cannabinoids have been identified in immune cells 1, 2, where several orphan G protein-coupled ...
openaire   +3 more sources

GPR55 Inactivation Diminishes Splenic Responses and Improves Neurological Outcomes in the Mouse Ischemia/Reperfusion Stroke Model

open access: yesCells
Although strokes are frequent and severe, treatment options are scarce. Plasminogen activators, the only FDA-approved agents for clot treatment (tissue plasminogen activators (tPAs)), are used in a limited patient group.
Sachin Gajghate, Hongbo Li, Slava Rom
doaj   +1 more source

GPR55: a new promising target for metabolism?

open access: yes, 2017
GPR55 is a G-protein-coupled receptor (GPCR) that has been identified as a new cannabinoid receptor. Given the wide localization of GPR55 in brain and peripheral tissues, this receptor has emerged as a regulator of multiple biological actions ...
Rubén Nogueiras   +6 more
core   +1 more source

Peptide-guided targeting of GPR55 for anti-cancer therapy

open access: yes, 2016
Purpose: Expression of the lysophosphatidylinositol receptor GPR55 correlates with invasive potential of metastatic cells and bone metastasis formation of different types of tumors. These findings suggest a role for GPR55 signaling in cancer progression.
Scala G   +4 more
core  

Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55

open access: yesNature Communications
GPR55 is an orphan G protein-coupled receptor (GPCR) and represents a promising drug target for cancer, inflammation, and metabolic diseases. The endogenous activation of lipid GPCRs can be solely mediated by membrane components and different lipids have
Tobias Claff   +5 more
doaj   +1 more source

Einfluss von Cannabinoiden auf die Proliferation humaner Glioblastomzellen via GPR55-Rezeptor und GPR55-assoziierter Signalwege [PDF]

open access: yes
Numerous studies reported on tumor suppressive effects of cannabinoids, which were mostly mediated by cannabinoid-specific receptors such as CB1 or CB2.
Kolbe, Marc Richard
core   +1 more source

Discovery and pharmacological evaluation of a novel series of chromenopyrazole-based GPR55 modulators in an androgen-driven model of female metabolic dysfunction

open access: yesEuropean Journal of Medicinal Chemistry Reports
GPR55 is a lipid-responsive G-protein-coupled receptor implicated in metabolic regulation, but its characterization has been limited by the poor selectivity and pathway bias of classical ligands.
Francisco J. Ponce-Díaz   +12 more
doaj   +1 more source

Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management

open access: yes, 2013
Dinorah Leyva-Illades,1–3 Sharon DeMorrow1–3 1Digestive Disease Research Center, Scott and White Hospital, Temple, TX, USA; 2Department of Internal MedicineTexas A&M Health Science Center, Temple, TX, USA; 3Research Service, Central Texas
Leyva-Illades D, DeMorrow S
core  

Home - About - Disclaimer - Privacy